Further characterization of Shigella-specific (memory) B cells induced in healthy volunteer recipients of SF2a-TT15, a Shigella flexneri 2a synthetic glycan-based vaccine candidate

Shigellosis is common worldwide, and it causes significant morbidity and mortality mainly in young children in low- and middle- income countries. To date, there are not broadly available licensed Shigella vaccines. A novel type of conjugate vaccine candidate, SF2a-TT15, was developed against S. flex...

Descripción completa

Detalles Bibliográficos
Autores principales: Toapanta, Franklin R., Hu, Jingping, Meron-Sudai, Shiri, Mulard, Laurence A., Phalipon, Armelle, Cohen, Dani, Sztein, Marcelo B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653583/
https://www.ncbi.nlm.nih.gov/pubmed/38022674
http://dx.doi.org/10.3389/fimmu.2023.1291664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653583/
https://www.ncbi.nlm.nih.gov/pubmed/38022674
http://dx.doi.org/10.3389/fimmu.2023.1291664

Ejemplares similares